Transcatheter Embolization And Occlusion Devices Market Report 2026

Transcatheter Embolization And Occlusion Devices Market Overview

• Transcatheter Embolization And Occlusion Devices market size has reached to $5.23 billion in 2025 • Expected to grow to $8.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: The Growing Demand for Minimally Invasive Techniques Fueling the Growth of the Market Due to Reduced Trauma and Faster Patient Recovery • Market Trend: Innovative Liquid Embolic System Advancing Minimally Invasive Vascular Treatment • North America was the largest region in 2025.

What Is Covered Under Transcatheter Embolization And Occlusion Devices Market?

Transcatheter Embolization and Occlusion Devices are medical tools used in minimally invasive procedures to block blood flow in specific areas of the body. These devices are delivered through a catheter, which is a thin, flexible tube inserted into the vascular system. The primary goal of these procedures is to treat or manage various medical conditions by obstructing the blood supply to certain tissues or organs. The main types of transcatheter embolization and occlusion devices are coil and non-coil. Coil devices are small, wire-like structures used in transcatheter embolization procedures to block blood flow to certain areas, often to treat aneurysms or prevent blood flow to tumors. It has applications such as peripheral vascular disease, oncology, neurology, urology, and others, and is used by end-users such as hospitals, ambulatory surgical centers, clinics, and others.

What Is The Transcatheter Embolization And Occlusion Devices Market Growth Forecast?

The transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $8.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for targeted embolization therapies, rising adoption of advanced embolic materials, expansion of oncology and neurointerventional procedures, growing focus on precision medicine, increasing investments in interventional healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising demand for advanced liquid embolic agents, growing use of detachable and coated coils, expansion of image-guided interventional techniques, enhanced focus on precision occlusion technologies.

What Is The Driver Of The Transcatheter Embolization And Occlusion Devices Market?

The growing demand for minimally invasive surgical techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries involve the use of small incisions or robotic-assisted tools to access internal structures while minimizing tissue damage, resulting in reduced trauma, shorter recovery times, less postoperative pain, and a lower risk of complications. The increasing preference for these procedures is driven by advancements in surgical technology, greater patient awareness of less-invasive options, and improved clinical outcomes. Transcatheter embolization and occlusion devices support such minimally invasive interventions by enabling targeted, catheter-based treatment with high precision and minimal disruption to surrounding tissues. For instance, in January 2025, according to Intuitive Surgical, Inc., a US-based medical technology corporation, full-year 2024 worldwide da Vinci procedures increased by approximately 17% compared with 2023. The company expects worldwide da Vinci procedures to grow by approximately 13% to 16% in 2025 compared with 2024. Therefore, the increasing adoption of minimally invasive techniques is driving the growth of the transcatheter embolization and occlusion devices industry.

Key Players In The Global Transcatheter Embolization And Occlusion Devices Market

Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular

Global Transcatheter Embolization And Occlusion Devices Market Trends and Insights

Major companies operating in the transcatheter embolization and occlusion devices market are focusing on developing advanced solutions, such as liquid embolic systems, to meet the rising demand for minimally invasive vascular interventions and effective control of arterial hemorrhage. A liquid embolic system refers to a non-adhesive, polymer-based embolization technology that is delivered through a microcatheter and solidifies upon contact with blood, enabling controlled occlusion of abnormal or damaged vessels while offering deeper penetration and greater precision than traditional coil-based methods. For instance, in July 2025, Medtronic plc., a US-based medical technology company, launched the Onyx Liquid Embolic System (LES) into clinical evaluation through its IDE study for embolization of arterial hemorrhage in the peripheral vasculature. This innovation uses an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and mixed with tantalum powder for radiopacity, allowing physicians to visualize and control the delivery in real time. It forms a cohesive embolus as the solvent diffuses, enabling targeted vessel occlusion with reduced risk of catheter entrapment and improved safety in complex anatomies. Designed for use in active peripheral arterial bleeding, the system enhances precision, supports minimally invasive treatment workflows, and expands therapeutic options for interventional specialists.

What Are Latest Mergers And Acquisitions In The Transcatheter Embolization And Occlusion Devices Market?

In February 2025, Stryker Corporation, a US-based healthcare technology company, acquired Inari Medical Inc. for an undisclosed amount. With this acquisition, Stryker aimed to expand its presence in the high-growth peripheral vascular intervention market and strengthen its portfolio with advanced venous thrombectomy technologies. Inari Medical Inc. is a US-based medical device company that specializes in providing minimally invasive mechanical thrombectomy systems and developing transcatheter mechanical thrombectomy systems.

What Defines the Transcatheter Embolization And Occlusion Devices Market?

The transcatheter embolization and occlusion devices market consists of sales of microspheres, gelatin sponges, and coil-assisted detachable balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Transcatheter Embolization And Occlusion Devices Market Report 2026?

The transcatheter embolization and occlusion devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter embolization and occlusion devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.